TransDigm Group Incorporated
TDGLast close · Oct 16, 20261,139.34+5.10 (+0.45%)
Market cap$63.0B
9 firms' latest targets, last 90 days: median $1,405.00 ($1,200.00–$1,745.00), 23% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-16 | Morgan Stanley | $1,300.00 | ▼ 7% | +14% |
| 2026-10-15 | RBC Capital | $1,200.00 | ▼ 11% | +5% |
| 2026-10-12 | Goldman Sachs | $1,745.00 | ▼ 7% | +53% |
| 2026-09-28 | BMO Capital | $1,400.00 | ▼ 10% | +23% |
| 2026-09-14 | Melius Research | $1,331.00 | — | +17% |
| 2026-08-10 | Wells Fargo | $1,450.00 | — | +27% |
| 2026-08-09 | Jefferies | $1,625.00 | ▲ 3% | +43% |
| 2026-08-05 | UBS | $1,695.00 | ▲ 3% | +49% |
| 2026-08-05 | Stifel | $1,405.00 | ▼ 8% | +23% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $6.6B | +21% | $22.03 | +64% | est. $6.6B+0% | est. $25.33 | 13 |
| 2024reported | $7.9B | +21% | $25.62 | +16% | est. $8.4B-5% | est. $29.66 | 7 |
| 2025reported | $8.8B | +11% | $32.08 | +25% | est. $8.8B+0% | est. $36.60 | 13 |
| 2026 | $10.5B | +19% | $41.16 | +12% | $10.5B–$10.6B | $40.69–$41.69 | 16 |
| 2027 | $11.7B | +12% | $48.60 | +18% | $11.4B–$11.9B | $46.52–$50.79 | 15 |
| 2028 | $12.6B | +7% | $55.52 | +14% | $11.8B–$13.2B | $41.57–$63.91 | 17 |
| 2029 | $13.4B | +7% | $64.01 | +15% | $12.9B–$13.7B | $46.77–$81.25 | 3 |
| 2030 | $14.4B | +8% | $72.00 | +12% | $13.8B–$14.9B | $68.27–$75.23 | 1 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.